Registry for treating parietal endometriosis with cryoablation and surgery
Official title: National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis
Run by Centre Hospitalier Intercommunal Creteil · NCT06356831 · Data updated 2026-11-12
This study is tracking how well cryoablation and surgery work for people with parietal endometriosis over three years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 300 (estimated) |
| Sponsor | Centre Hospitalier Intercommunal Creteil Academic / other |
| Locations | 18 sites (Bordeau and 17 other locations) |
| Status | Recruiting |
| Started | June 15, 2024 |
| Main results expected | July 31, 2027 |
| Study ends | January 31, 2028 |
| Registry record updated | November 28, 2025 |
| Trial ID | NCT06356831 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women with symptomatic parietal endometriosis confirmed by clinical and imaging criteria.
✕Probably not a fit
Patients with endometriosis not affecting the anterior abdominal wall or those with contraindications to MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This national multicentric registry collects data on patients suffering from parietal endometriosis who are treated with cryoablation or surgical interventions. The registry aims to follow these patients for three years post-treatment to assess outcomes and effectiveness. A multidisciplinary radiosurgery team will oversee the data collection and patient management, ensuring comprehensive care and monitoring.
Why it matters
Potential benefit: If successful, this registry could improve treatment strategies and outcomes for patients with parietal endometriosis.
How similar studies have gone: While similar approaches have been utilized in other studies, this specific registry for parietal endometriosis treatment is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Presence of parietal endometriosis: with suggestive clinical and imaging criteria (MRI and ultrasound) * Symptomatic parietal endometriosis (VAS \> 3 OR bothersome bleeding OR reported impact on quality of life) Exclusion Criteria: * Endometriosis not affecting the anterior wall of the abdomen (as deep pelvic muscle: ilio-psoas, obturators, perineal, ischio-anal fossa) * Minor patient (\< 18 years) * Pregnant patient at any trimester * Patient with hemostasis disorders (constitutional or acquired) * Patient with systemic infection or localized scar infection upon inclusion. * Patient with contraindications to MRI * Female patient with a planned medical or surgical procedure for the duration of the study that may interfere with the proper conduct of the study. * Patient unable to understand the information provided * Patient who is not affiliated to the social security system * Patient under curatorship or tutorship * Patient with a nodule of primary or secondary malignant tumor origin
Where it's running
-
CHU bordeaux
Bordeau, France Recruiting -
Clinique Tivoli
Bordeaux, France Recruiting -
CHU Clermont Ferrand
Clermont-Ferrand, France Recruiting -
CHI Creteil
Créteil, France Recruiting -
Lyon Hôpital La Croix Rousse
Lyon, France Recruiting -
Lyon Hôpital Sud
Lyon, France Recruiting
Show 12 more locations
-
APHP-Hôpital la Conception La Timone
Marseille, France Recruiting -
CHU Montpellier
Montpellier, France Recruiting -
CHU Nime
Nîmes, France Recruiting -
AP-HP - Tenon
Paris, France Recruiting -
AP-HP Hôpital Européen Georges Pompidou
Paris, France Recruiting -
APHP Cochin-Port Royal
Paris, France Recruiting -
APHP-La Pitié
Paris, France Recruiting -
CH Valencienne
Valenciennes, France Recruiting -
Lyon Louis Pradel
Lyon, France Active not recruiting -
APHM-Hôpital Nord
Marseille, France Active not recruiting -
CHU Strasbourg
Strasbourg, France Enrolling by invitation -
CHU Toulouse
Toulouse, France Active not recruiting
Study contacts
- Principal investigator: Léo RAZAKAMAMANTSOA — Chic
- Study coordinator: Léo Razakamanantsoa, Dr
- Email: Leo.Razakamanantsoa@chicreteil.fr
- Phone: 0157023567
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Virtual Reality Therapy to Improve Arthroplasty Outcomes
This pilot test checks whether using virtual reality during the perioperative period helps knee or hip replacement patients feel better about their care and recover more easily.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.